|

Tucidinostat Clinical Trials

2 actively recruiting trials

Also known as: Chidamide

Pipeline

Phase 3: 2

Top Sponsors

  • Chipscreen Biosciences, Ltd.2

Indications

  • Cancer2
  • Lymphoma, T-Cell, Peripheral1
  • Colorectal Cancer1

Other2 trials

A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
Phase 3
Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.